A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 385-391

  Maliartchouk, Sergei ^a   Feng, Yangbo ^c   Ivanisevic, Ljubica ^a   Debeir, Thomas ^a   Cuello, A Claudio ^a   Burgess, Kevin ^c   Saragovi, H Uri ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; COMPOUND D3; LIGAND; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR AGONIST; PEPTIDOMIMETIC AGONIST; PROTEIN TYROSINE KINASE NEUROTROPHIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; GROWTH REGULATION; HUMAN; HUMAN CELL; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION;

ANIMALS; BINDING, COMPETITIVE; CELL DIFFERENTIATION; CELLS, CULTURED; DIMERIZATION; FETUS; GANGLIA, SPINAL; HUMANS; LIGANDS; MOLECULAR MIMICRY; NERVE GROWTH FACTORS; NEURONS; PEPTIDE HYDROLASES; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN STRUCTURE, SECONDARY; RATS; RECEPTOR, TRKA;

EID: 0033952847     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barbacid M (1994) The Trk family of neurotrophin receptors. J Neurobiol 25:1386-1403.
2. Barinaga M (1994) Neurotrophic factors enter the clinic. Science 264:272-274.
3. Beglova N, LeSauteur L, Saragovi H and Gehring KB (1998) Solution structure and internal motion of a bioactive peptide derived from nerve growth factor. J Biol Chem 273:23652-23658.
4. NTR decide? Neuron 18:187-190.
5. Cortazzo MH, Kassis ES, Sproul KA and Schor, NF (1996) Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor. J Neurosci 16:3895-3899.
6. Debeir T, Saragovi HU and Cuello, AC (1999) An NGF antagonist mimetic provokes retrieval of cortical cholinergic presynaptic boutons in the brain of the adult rat. Proc Natl Acad Sci USA 96:4067-4072.
7. Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR and Lassi NK (1997) Neurotrophins and their receptors in nerve injury and repair. Neurochem Int. 30:347-374.
8. Feng Y, Wang Z, Jin S and Burgess, K (1998) SNAr cyclizations to form cyclic peptidomimetics of β-turns. J Am Chem Soc 120:10768-10769.
9. Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409.
10. Hefti F, Hartikka J, Eckenstein F, Gnahn H, Heumann R and Schwab M (1985) Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons. Neuroscience 14:55-68.
11. Hughes PE, Alexi T and Knusel B (1997) Axotomized septal cholinergic neurons rescued by nerve growth factor. Neuroscience 78:1037.
12. Kaplan DR and Stephens RM (1994) Neurotrophin signal transduction by the Trk receptor. J Neurobiol 25:1404-1417.
13. Kimpinski K, Campenot R and Mearow K (1997) Effects of the neurotrophins nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor (BDNF) on neunte growth from adult sensory neurons in compartmented cultures. J Neurobiol 33:395-410.
14. LeSauteur L, Cheung N-KV, Lisbona R and Saragovi HU (1996a) Small molecule nerve growth factor analogs image receptors in vivo. Nat Biotech 14:1120-1122.
15. LeSauteur L, Maliartchouk S, Jeune HL, Quirion R and Saragovi HU (1996b) Potent human p140-TrkA agonists derived from an anti-receptor antibody. J Neurosci 16:1308-1316.
16. LeSauteur L, Wei L, Gibbs B and Saragovi HU (1995) Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270:6564-6569.
17. Lindsay R (1996) Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases. Ciba Foundation Symposium 196:39-53.
18. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, and Wilson IA (1999) Crystallographic evidence for preformed dimers of erytrhopoietin receptor before ligand activation. Science 283:987-990.
19. Maliartchouk S and Saragovi HU (1997) Optimal NGF trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands. J Neurosci 17:6031-6037.
20. Maroney A, Glicksman M, Basma A, Walton K, Knight EJ, Murphy C, Bartlett B, Finn J, Angeles T, Matsuda Y, Neff N and Dionne C (1998) Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci 18:104-111.
21. Milligan G, Bond RA and Lee M (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharm Sci 18:10-13.
22. Owolabi J, Rizkalla G, Tehim A, Ross G, Riopelle R, Kamboj R, Ossipov M, Bian D, Wegert S, Porreca F and Lee D (1999) Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther 289:1271-1276.
23. Perez P, Coll PM, Hempstead BL, Martin-Zanca D and Chao MV (1995) NGF binding to the Trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol Cell Neurosci 6:97-105.
24. Reddy CC, Niyogi SK, Wells A, Wiley HS and Lauffenburger DA (1996) Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotech 14:1696-1699.
25. Remy I, Wilson IA and Michnick S (1999) Erythropoietin receptor activation by ligand-induced conformation change. Science 283:990-993.
26. Saragovi HU and Burgess K (1999) Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents. Expert Opin Ther Patents 9:737-751.
27. Saragovi HU, Fitzpatrick D, Raktabuhr A, Nakanishi H, Kahn M and Greene MI (1991) Design and synthesis of a mimetic of an antibody complementarity region. Science 253:792-795.
28. Saragovi HU, Greene MI, Chrusciel RA and Kahn M (1992) Loops and secondary structure mimetics: Development and applications in basic science and rational drug design. Biotechnology 10:773-778.
29. Saragovi HU, Zheng WH, Maliartchouk S, DiGugliemo GM, Mawal YR, Kamen A, Woo SB, Cuello AC, Debeir T and Neet KE (1998) A TrkA selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals. J Biol Chem 274:34933-34940.
30. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li J-HJ, Huang W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC and Suzkak PD (1997) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 94:2019-2024.
31. Tian S, Lamb P, King A, Miller S, Kessler L, Luengo J, Averill L, Johnson R, Gleason J, Pelus L, Dillon S and Rosen J (1998) A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science 281:257-259.
32. Verrall M (1994) Lay-offs follow suspension of clinical trials of protein. Nature 370:6.
33. Vogelbaum M, Tong J and Rich K (1998) Developmental regulation of apoptosis in dorsal root ganglion neurons. J Neurosci 18:8928-8935.
34. Wells JA (1996) Hormone mimicry. Science 273:449-450.
35. Windisch JM, Marksteiner R and Schneider R (1995) Nerve growth factor binding site on TrkA mapped to a single 24-amino acid leucine-rich motif. J Biol Chem 270:28133-28138.
36. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK and Dower WJ (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-463.
37. Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I, Vilella D, Diez MT, Pelaez F, Ruby C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG and Moller DE (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284:974-977.